# A Study Designed to Evaluate Tear Production

> **NCT06544707** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 81 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** 0.003% AR-15512 ophthalmic solution

## Key facts

- **NCT ID:** NCT06544707
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-15
- **Primary completion:** 2025-01-30
- **Final completion:** 2025-01-30
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06544707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06544707, "A Study Designed to Evaluate Tear Production". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06544707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*